These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

394 related items for PubMed ID: 22172392

  • 1. Initial evaluation in healthy humans of [18F]DPA-714, a potential PET biomarker for neuroinflammation.
    Arlicot N, Vercouillie J, Ribeiro MJ, Tauber C, Venel Y, Baulieu JL, Maia S, Corcia P, Stabin MG, Reynolds A, Kassiou M, Guilloteau D.
    Nucl Med Biol; 2012 May; 39(4):570-8. PubMed ID: 22172392
    [Abstract] [Full Text] [Related]

  • 2. In vivo imaging and characterization of [(18)F]DPA-714, a potential new TSPO ligand, in mouse brain and peripheral tissues using small-animal PET.
    Vicidomini C, Panico M, Greco A, Gargiulo S, Coda AR, Zannetti A, Gramanzini M, Roviello GN, Quarantelli M, Alfano B, Tavitian B, Dollé F, Salvatore M, Brunetti A, Pappatà S.
    Nucl Med Biol; 2015 Mar; 42(3):309-16. PubMed ID: 25537727
    [Abstract] [Full Text] [Related]

  • 3. Optimized Quantification of Translocator Protein Radioligand ¹⁸F-DPA-714 Uptake in the Brain of Genotyped Healthy Volunteers.
    Lavisse S, García-Lorenzo D, Peyronneau MA, Bodini B, Thiriez C, Kuhnast B, Comtat C, Remy P, Stankoff B, Bottlaender M.
    J Nucl Med; 2015 Jul; 56(7):1048-54. PubMed ID: 26025960
    [Abstract] [Full Text] [Related]

  • 4. 11C-DPA-713 Versus 18F-GE-180: A Preclinical Comparison of Translocator Protein 18 kDa PET Tracers to Visualize Acute and Chronic Neuroinflammation in a Mouse Model of Ischemic Stroke.
    Chaney A, Cropper HC, Johnson EM, Lechtenberg KJ, Peterson TC, Stevens MY, Buckwalter MS, James ML.
    J Nucl Med; 2019 Jan; 60(1):122-128. PubMed ID: 29976695
    [Abstract] [Full Text] [Related]

  • 5. Comparative evaluation of the translocator protein radioligands 11C-DPA-713, 18F-DPA-714, and 11C-PK11195 in a rat model of acute neuroinflammation.
    Chauveau F, Van Camp N, Dollé F, Kuhnast B, Hinnen F, Damont A, Boutin H, James M, Kassiou M, Tavitian B.
    J Nucl Med; 2009 Mar; 50(3):468-76. PubMed ID: 19223401
    [Abstract] [Full Text] [Related]

  • 6. Evaluation of PET Imaging Performance of the TSPO Radioligand [18F]DPA-714 in Mouse and Rat Models of Cancer and Inflammation.
    Zheng J, Winkeler A, Peyronneau MA, Dollé F, Boisgard R.
    Mol Imaging Biol; 2016 Feb; 18(1):127-34. PubMed ID: 26194010
    [Abstract] [Full Text] [Related]

  • 7. Metabolism and quantification of [(18)F]DPA-714, a new TSPO positron emission tomography radioligand.
    Peyronneau MA, Saba W, Goutal S, Damont A, Dollé F, Kassiou M, Bottlaender M, Valette H.
    Drug Metab Dispos; 2013 Jan; 41(1):122-31. PubMed ID: 23065531
    [Abstract] [Full Text] [Related]

  • 8. [18F]DPA-714 PET imaging of translocator protein TSPO (18 kDa) in the normal and excitotoxically-lesioned nonhuman primate brain.
    Lavisse S, Inoue K, Jan C, Peyronneau MA, Petit F, Goutal S, Dauguet J, Guillermier M, Dollé F, Rbah-Vidal L, Van Camp N, Aron-Badin R, Remy P, Hantraye P.
    Eur J Nucl Med Mol Imaging; 2015 Mar; 42(3):478-94. PubMed ID: 25488184
    [Abstract] [Full Text] [Related]

  • 9. Quantification of TSPO overexpression in a rat model of local neuroinflammation induced by intracerebral injection of LPS by the use of [(18)F]DPA-714 PET.
    Ory D, Postnov A, Koole M, Celen S, de Laat B, Verbruggen A, Van Laere K, Bormans G, Casteels C.
    Eur J Nucl Med Mol Imaging; 2016 Jan; 43(1):163-172. PubMed ID: 26323575
    [Abstract] [Full Text] [Related]

  • 10. [18F]DPA-714: Effect of co-medications, age, sex, BMI and TSPO polymorphism on the human plasma input function.
    Peyronneau MA, Kuhnast B, Nguyen DL, Jego B, Sayet G, Caillé F, Lavisse S, Gervais P, Stankoff B, Sarazin M, Remy P, Bouilleret V, Leroy C, Bottlaender M.
    Eur J Nucl Med Mol Imaging; 2023 Sep; 50(11):3251-3264. PubMed ID: 37291448
    [Abstract] [Full Text] [Related]

  • 11. Differential influence of propofol and isoflurane anesthesia in a non-human primate on the brain kinetics and binding of [(18)F]DPA-714, a positron emission tomography imaging marker of glial activation.
    Saba W, Goutal S, Kuhnast B, Dollé F, Auvity S, Fontyn Y, Cayla J, Peyronneau MA, Valette H, Tournier N.
    Eur J Neurosci; 2015 Jul; 42(1):1738-45. PubMed ID: 25962575
    [Abstract] [Full Text] [Related]

  • 12. Biodistribution and Radiation Dosimetry of 124I-DPA-713, a PET Radiotracer for Macrophage-Associated Inflammation.
    Foss CA, Plyku D, Ordonez AA, Sanchez-Bautista J, Rosenthal HB, Minn I, Lodge MA, Pomper MG, Sgouros G, Jain SK.
    J Nucl Med; 2018 Nov; 59(11):1751-1756. PubMed ID: 29700124
    [Abstract] [Full Text] [Related]

  • 13. Parametric Binding Images of the TSPO Ligand 18F-DPA-714.
    Golla SS, Boellaard R, Oikonen V, Hoffmann A, van Berckel BN, Windhorst AD, Virta J, Te Beek ET, Groeneveld GJ, Haaparanta-Solin M, Luoto P, Savisto N, Solin O, Valencia R, Thiele A, Eriksson J, Schuit RC, Lammertsma AA, Rinne JO.
    J Nucl Med; 2016 Oct; 57(10):1543-1547. PubMed ID: 27261521
    [Abstract] [Full Text] [Related]

  • 14. Initial evaluation of 11C-DPA-713, a novel TSPO PET ligand, in humans.
    Endres CJ, Pomper MG, James M, Uzuner O, Hammoud DA, Watkins CC, Reynolds A, Hilton J, Dannals RF, Kassiou M.
    J Nucl Med; 2009 Aug; 50(8):1276-82. PubMed ID: 19617321
    [Abstract] [Full Text] [Related]

  • 15. Impact of Endothelial 18-kDa Translocator Protein on the Quantification of 18F-DPA-714.
    Wimberley C, Lavisse S, Brulon V, Peyronneau MA, Leroy C, Bodini B, Remy P, Stankoff B, Buvat I, Bottlaender M.
    J Nucl Med; 2018 Feb; 59(2):307-314. PubMed ID: 28775204
    [Abstract] [Full Text] [Related]

  • 16. The translocator protein ligand [¹⁸F]DPA-714 images glioma and activated microglia in vivo.
    Winkeler A, Boisgard R, Awde AR, Dubois A, Thézé B, Zheng J, Ciobanu L, Dollé F, Viel T, Jacobs AH, Tavitian B.
    Eur J Nucl Med Mol Imaging; 2012 May; 39(5):811-23. PubMed ID: 22270507
    [Abstract] [Full Text] [Related]

  • 17. Quantitative assessment of translocator protein (TSPO) in the non-human primate brain and clinical translation of [18F]LW223 as a TSPO-targeted PET radioligand.
    Tan Z, Haider A, Zhang S, Chen J, Wei J, Liao K, Li G, Wei H, Dong C, Ran W, Li Y, Li Y, Rong J, Li Y, Liang SH, Xu H, Wang L.
    Pharmacol Res; 2023 Mar; 189():106681. PubMed ID: 36746361
    [Abstract] [Full Text] [Related]

  • 18. Radiation dosimetry and biodistribution of the TSPO ligand 11C-DPA-713 in humans.
    Endres CJ, Coughlin JM, Gage KL, Watkins CC, Kassiou M, Pomper MG.
    J Nucl Med; 2012 Feb; 53(2):330-5. PubMed ID: 22241913
    [Abstract] [Full Text] [Related]

  • 19. Initial Evaluation of an Adenosine A2A Receptor Ligand, 11C-Preladenant, in Healthy Human Subjects.
    Sakata M, Ishibashi K, Imai M, Wagatsuma K, Ishii K, Zhou X, de Vries EFJ, Elsinga PH, Ishiwata K, Toyohara J.
    J Nucl Med; 2017 Sep; 58(9):1464-1470. PubMed ID: 28280214
    [Abstract] [Full Text] [Related]

  • 20. DPA-714, a new translocator protein-specific ligand: synthesis, radiofluorination, and pharmacologic characterization.
    James ML, Fulton RR, Vercoullie J, Henderson DJ, Garreau L, Chalon S, Dolle F, Costa B, Guilloteau D, Kassiou M.
    J Nucl Med; 2008 May; 49(5):814-22. PubMed ID: 18413395
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.